Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 158

1.

Characterization of Lead Compounds Targeting the Selenoprotein Thioredoxin Glutathione Reductase for Treatment of Schistosomiasis.

Lyu H, Petukhov PA, Banta PR, Jadhav A, Lea WA, Cheng Q, Arnér ESJ, Simeonov A, Thatcher GRJ, Angelucci F, Williams DL.

ACS Infect Dis. 2020 Mar 13;6(3):393-405. doi: 10.1021/acsinfecdis.9b00354. Epub 2020 Jan 24.

PMID:
31939288
2.

Ectopic suicide inhibition of thioredoxin glutathione reductase.

Silvestri I, Lyu H, Fata F, Banta PR, Mattei B, Ippoliti R, Bellelli A, Pitari G, Ardini M, Petukhova V, Thatcher GRJ, Petukhov PA, Williams DL, Angelucci F.

Free Radic Biol Med. 2020 Feb 1;147:200-211. doi: 10.1016/j.freeradbiomed.2019.12.019. Epub 2019 Dec 20.

PMID:
31870799
3.

Impact of APOE and BDNF Val66Met Gene Polymorphisms on Cognitive Functions in Patients with Amnestic Mild Cognitive Impairment.

Cechova K, Andel R, Angelucci F, Chmatalova Z, Markova H, Laczó J, Vyhnalek M, Matoska V, Kaplan V, Nedelska Z, Ward DD, Hort J.

J Alzheimers Dis. 2020;73(1):247-257. doi: 10.3233/JAD-190464.

PMID:
31771052
4.

Administration of pre/probiotics with conventional drug treatment in Alzheimer's disease.

Hort J, Valis M, Angelucci F.

Neural Regen Res. 2020 Mar;15(3):448-449. doi: 10.4103/1673-5374.266057. No abstract available.

5.

Keratoderma-Deafness-Mucocutaneous Syndrome Associated with Phe142Leu in the GJB2 Gene.

Guerra L, Bergamo F, D'Apice MR, Angelucci F, di Girolamo S, Camerota L, Monetta R, Annessi G, Castiglia D, Novelli G, Paradisi M, Brancati F.

Acta Derm Venereol. 2019 Nov 1;99(12):1192-1194. doi: 10.2340/00015555-3291. No abstract available.

6.

MicroRNAs in Alzheimer's Disease: Diagnostic Markers or Therapeutic Agents?

Angelucci F, Cechova K, Valis M, Kuca K, Zhang B, Hort J.

Front Pharmacol. 2019 Jun 18;10:665. doi: 10.3389/fphar.2019.00665. eCollection 2019. Review.

7.

Antibiotics, gut microbiota, and Alzheimer's disease.

Angelucci F, Cechova K, Amlerova J, Hort J.

J Neuroinflammation. 2019 May 22;16(1):108. doi: 10.1186/s12974-019-1494-4. Review.

8.

Vascular Cognitive Impairment: Information from Animal Models on the Pathogenic Mechanisms of Cognitive Deficits.

Hort J, Vališ M, Kuča K, Angelucci F.

Int J Mol Sci. 2019 May 15;20(10). pii: E2405. doi: 10.3390/ijms20102405. Review.

9.

CGRP in a gene-environment interaction model for depression: effects of antidepressant treatment.

Angelucci F, Ellenbroek BA, El Khoury A, Mathé AA.

Acta Neuropsychiatr. 2019 Apr;31(2):93-99. doi: 10.1017/neu.2018.31. Epub 2018 Dec 4.

PMID:
30509331
10.

YAP/TAZ mechano-transduction as the underlying mechanism of neuronal differentiation induced by reduced graphene oxide.

Catanesi M, Panella G, Benedetti E, Fioravanti G, Perrozzi F, Ottaviano L, Leandro LD, Ardini M, Giansanti F, d'Angelo M, Castelli V, Angelucci F, Ippoliti R, Cimini A.

Nanomedicine (Lond). 2018 Dec;13(24):3091-3106. doi: 10.2217/nnm-2018-0269. Epub 2018 Nov 19.

PMID:
30451074
11.

Amyloid beta soluble forms and plasminogen activation system in Alzheimer's disease: Consequences on extracellular maturation of brain-derived neurotrophic factor and therapeutic implications.

Angelucci F, Čechová K, Průša R, Hort J.

CNS Neurosci Ther. 2019 Mar;25(3):303-313. doi: 10.1111/cns.13082. Epub 2018 Nov 6. Review.

12.

Recessive mutations in the neuronal isoforms of DST, encoding dystonin, lead to abnormal actin cytoskeleton organization and HSAN type VI.

Fortugno P, Angelucci F, Cestra G, Camerota L, Ferraro AS, Cordisco S, Uccioli L, Castiglia D, De Angelis B, Kurth I, Kornak U, Brancati F.

Hum Mutat. 2019 Jan;40(1):106-114. doi: 10.1002/humu.23678. Epub 2018 Nov 18.

PMID:
30371979
13.

Fragment-Based Discovery of a Regulatory Site in Thioredoxin Glutathione Reductase Acting as "Doorstop" for NADPH Entry.

Silvestri I, Lyu H, Fata F, Boumis G, Miele AE, Ardini M, Ippoliti R, Bellelli A, Jadhav A, Lea WA, Simeonov A, Cheng Q, Arnér ESJ, Thatcher GRJ, Petukhov PA, Williams DL, Angelucci F.

ACS Chem Biol. 2018 Aug 17;13(8):2190-2202. doi: 10.1021/acschembio.8b00349. Epub 2018 Jun 11.

14.

A peroxiredoxin-based proteinaceous scaffold for the growth and differentiation of neuronal cells and tumour stem cells in the absence of prodifferentiation agents.

Cimini A, Ardini M, Gentile R, Giansanti F, Benedetti E, Cristiano L, Fidoamore A, Scotti S, Panella G, Angelucci F, Ippoliti R.

J Tissue Eng Regen Med. 2017 Sep;11(9):2462-2470. doi: 10.1002/term.2144. Epub 2016 Feb 8.

PMID:
29737636
15.

Cerebellar BDNF Promotes Exploration and Seeking for Novelty.

Laricchiuta D, Andolina D, Angelucci F, Gelfo F, Berretta E, Puglisi-Allegra S, Petrosini L.

Int J Neuropsychopharmacol. 2018 May 1;21(5):485-498. doi: 10.1093/ijnp/pyy015.

16.

Strategies to Improve the Clinical Utility of Saporin-Based Targeted Toxins.

Giansanti F, Flavell DJ, Angelucci F, Fabbrini MS, Ippoliti R.

Toxins (Basel). 2018 Feb 13;10(2). pii: E82. doi: 10.3390/toxins10020082. Review.

17.

EV20-Sap, a novel anti-HER-3 antibody-drug conjugate, displays promising antitumor activity in melanoma.

Capone E, Giansanti F, Ponziani S, Lamolinara A, Iezzi M, Cimini A, Angelucci F, Sorda R, Laurenzi V, Natali PG, Ippoliti R, Iacobelli S, Sala G.

Oncotarget. 2017 Sep 8;8(56):95412-95424. doi: 10.18632/oncotarget.20728. eCollection 2017 Nov 10.

18.

Management della retinopatia diabetica e dell'edema maculare diabetico: linee guida "Euretina 2017".

Turchetti P, Librando A, Angelucci F, Carlesimo SC, Migliorini R.

Clin Ter. 2017 Sep-Oct;168(5):e340-e343. doi: 10.7417/T.2017.2032.

19.

Targeted therapy of human glioblastoma via delivery of a toxin through a peptide directed to cell surface nucleolin.

Dhez AC, Benedetti E, Antonosante A, Panella G, Ranieri B, Florio TM, Cristiano L, Angelucci F, Giansanti F, Di Leandro L, d'Angelo M, Melone M, De Cola A, Federici L, Galzio R, Cascone I, Raineri F, Cimini A, Courty J, Giordano A, Ippoliti R.

J Cell Physiol. 2018 May;233(5):4091-4105. doi: 10.1002/jcp.26205. Epub 2017 Dec 18.

PMID:
28941284
20.

Infections in hospital departments. What is Hospital Responsibility?

Pacella F, Collini S, Angelucci F, Agostinelli E, Guzzo AS, Cerza C, Pacella E.

Clin Ter. 2017 Jul-Aug;168(4):e266-e270. doi: 10.7417/T.2017.2018. Review.

21.

Prolyl isomerase Pin1 and neurotrophins: a loop that may determine the fate of cells in cancer and neurodegeneration.

Angelucci F, Hort J.

Ther Adv Med Oncol. 2017 Jan;9(1):59-62. doi: 10.1177/1758834016665776. Epub 2016 Sep 16. Review.

22.

Optimization of construct design and fermentation strategy for the production of bioactive ATF-SAP, a saporin based anti-tumoral uPAR-targeted chimera.

Errico Provenzano A, Posteri R, Giansanti F, Angelucci F, Flavell SU, Flavell DJ, Fabbrini MS, Porro D, Ippoliti R, Ceriotti A, Branduardi P, Vago R.

Microb Cell Fact. 2016 Nov 14;15(1):194.

23.

Peripheral Brain-Derived Neurotrophic Factor Levels in Alzheimer's Disease and Mild Cognitive Impairment: a Comprehensive Systematic Review and Meta-analysis.

Kim BY, Lee SH, Graham PL, Angelucci F, Lucia A, Pareja-Galeano H, Leyhe T, Turana Y, Lee IR, Yoon JH, Shin JI.

Mol Neurobiol. 2017 Nov;54(9):7297-7311. doi: 10.1007/s12035-016-0192-9. Epub 2016 Nov 4.

PMID:
27815832
24.

Gene-environment interactions in a rat model of depression. Maternal separation affects neurotensin in selected brain regions.

Ellenbroek BA, Angelucci F, Husum H, Mathé AA.

Neuropeptides. 2016 Oct;59:83-88. doi: 10.1016/j.npep.2016.05.001. Epub 2016 May 25.

PMID:
27372546
25.

Typical 2-Cys peroxiredoxins in human parasites: Several physiological roles for a potential chemotherapy target.

Angelucci F, Miele AE, Ardini M, Boumis G, Saccoccia F, Bellelli A.

Mol Biochem Parasitol. 2016 Mar-Apr;206(1-2):2-12. doi: 10.1016/j.molbiopara.2016.03.005. Epub 2016 Mar 18. Review.

PMID:
27002228
26.

Supramolecular self-assembly of graphene oxide and metal nanoparticles into stacked multilayers by means of a multitasking protein ring.

Ardini M, Golia G, Passaretti P, Cimini A, Pitari G, Giansanti F, Di Leandro L, Ottaviano L, Perrozzi F, Santucci S, Morandi V, Ortolani L, Christian M, Treossi E, Palermo V, Angelucci F, Ippoliti R.

Nanoscale. 2016 Mar 28;8(12):6739-53. doi: 10.1039/c5nr08632a.

PMID:
26952635
27.

The effects of motor rehabilitation training on clinical symptoms and serum BDNF levels in Parkinson's disease subjects.

Angelucci F, Piermaria J, Gelfo F, Shofany J, Tramontano M, Fiore M, Caltagirone C, Peppe A.

Can J Physiol Pharmacol. 2016 Apr;94(4):455-61. doi: 10.1139/cjpp-2015-0322. Epub 2016 Feb 10.

PMID:
26863448
28.

Cognitive training in neurodegenerative diseases: a way to boost neuroprotective molecules?

Angelucci F, Caltagirone C, Costa A.

Neural Regen Res. 2015 Nov;10(11):1754-5. doi: 10.4103/1673-5374.169608. No abstract available.

29.

Interaction does Count: A Cross-Fostering Study on Transgenerational Effects of Pre-reproductive Maternal Enrichment.

Caporali P, Cutuli D, Gelfo F, Laricchiuta D, Foti F, De Bartolo P, Angelucci F, Petrosini L.

Front Behav Neurosci. 2015 Dec 1;9:320. doi: 10.3389/fnbeh.2015.00320. eCollection 2015.

30.

The Nutraceutical Properties of Ovotransferrin and Its Potential Utilization as a Functional Food.

Giansanti F, Leboffe L, Angelucci F, Antonini G.

Nutrients. 2015 Nov 4;7(11):9105-15. doi: 10.3390/nu7115453. Review.

31.

Brain-derived neurotrophic factor serum levels correlate with cognitive performance in Parkinson's disease patients with mild cognitive impairment.

Costa A, Peppe A, Carlesimo GA, Zabberoni S, Scalici F, Caltagirone C, Angelucci F.

Front Behav Neurosci. 2015 Sep 15;9:253. doi: 10.3389/fnbeh.2015.00253. eCollection 2015.

32.

BDNF concentration and impulsiveness level in post-traumatic stress disorder.

Martinotti G, Sepede G, Brunetti M, Ricci V, Gambi F, Chillemi E, Vellante F, Signorelli M, Pettorruso M, De Risio L, Aguglia E, Angelucci F, Caltagirone C, Di Giannantonio M.

Psychiatry Res. 2015 Oct 30;229(3):814-8. doi: 10.1016/j.psychres.2015.07.085. Epub 2015 Aug 6.

PMID:
26277035
33.

One ring (or two) to hold them all – on the structure and function of protein nanotubes.

Angelucci F, Bellelli A, Ardini M, Ippoliti R, Saccoccia F, Morea V.

FEBS J. 2015 Aug;282(15):2827-45. doi: 10.1111/febs.13336. Epub 2015 Jun 23. Review.

34.

Leishmania infantum trypanothione reductase is a promiscuous enzyme carrying an NADPH:O2 oxidoreductase activity shared by glutathione reductase.

Angiulli G, Lantella A, Forte E, Angelucci F, Colotti G, Ilari A, Malatesta F.

Biochim Biophys Acta. 2015 Sep;1850(9):1891-7. doi: 10.1016/j.bbagen.2015.05.022. Epub 2015 May 29.

PMID:
26033467
35.

A pilot study on the effect of cognitive training on BDNF serum levels in individuals with Parkinson's disease.

Angelucci F, Peppe A, Carlesimo GA, Serafini F, Zabberoni S, Barban F, Shofany J, Caltagirone C, Costa A.

Front Hum Neurosci. 2015 Mar 16;9:130. doi: 10.3389/fnhum.2015.00130. eCollection 2015.

36.

Pre-reproductive maternal enrichment influences rat maternal care and offspring developmental trajectories: behavioral performances and neuroplasticity correlates.

Cutuli D, Caporali P, Gelfo F, Angelucci F, Laricchiuta D, Foti F, De Bartolo P, Bisicchia E, Molinari M, Farioli Vecchioli S, Petrosini L.

Front Behav Neurosci. 2015 Mar 12;9:66. doi: 10.3389/fnbeh.2015.00066. eCollection 2015.

37.

PDZ Domain in the Engineering and Production of a Saporin Chimeric Toxin as a Tool for targeting Cancer Cells.

Giansanti F, Sabatini D, Pennacchio MR, Scotti S, Angelucci F, Dhez AC, Antonosante A, Cimini A, Giordano A, Ippoliti R.

J Cell Biochem. 2015 Jul;116(7):1256-66. doi: 10.1002/jcb.25080.

PMID:
25581839
38.

Age-related macular degeneration: insights into inflammatory genes.

Cascella R, Ragazzo M, Strafella C, Missiroli F, Borgiani P, Angelucci F, Marsella LT, Cusumano A, Novelli G, Ricci F, Giardina E.

J Ophthalmol. 2014;2014:582842. doi: 10.1155/2014/582842. Epub 2014 Nov 12. Review.

39.

Selenocysteine robustness versus cysteine versatility: a hypothesis on the evolution of the moonlighting behaviour of peroxiredoxins.

Saccoccia F, Angelucci F, Boumis G, Desiato G, Miele AE, Bellelli A.

Biochem Soc Trans. 2014 Dec;42(6):1768-72. doi: 10.1042/BST20140212. Review.

PMID:
25399604
40.

The crystal structure of archaeal serine hydroxymethyltransferase reveals idiosyncratic features likely required to withstand high temperatures.

Angelucci F, Morea V, Angelaccio S, Saccoccia F, Contestabile R, Ilari A.

Proteins. 2014 Dec;82(12):3437-49. doi: 10.1002/prot.24697. Epub 2014 Oct 10.

PMID:
25257552
41.

Lithium/Valproic acid combination and L-glutamate induce similar pattern of changes in the expression of miR-30a-5p in SH-SY5Y neuroblastoma cells.

Croce N, Bernardini S, Caltagirone C, Angelucci F.

Neuromolecular Med. 2014 Dec;16(4):872-7. doi: 10.1007/s12017-014-8325-7. Epub 2014 Aug 23.

PMID:
25149854
42.

The effect of neuropeptide Y on cell survival and neurotrophin expression in in-vitro models of Alzheimer's disease.

Angelucci F, Gelfo F, Fiore M, Croce N, Mathé AA, Bernardini S, Caltagirone C.

Can J Physiol Pharmacol. 2014 Aug;92(8):621-30. doi: 10.1139/cjpp-2014-0099. Epub 2014 Jun 13. Review.

PMID:
25026432
43.

Pre-reproductive maternal enrichment influences offspring developmental trajectories: motor behavior and neurotrophin expression.

Caporali P, Cutuli D, Gelfo F, Laricchiuta D, Foti F, De Bartolo P, Mancini L, Angelucci F, Petrosini L.

Front Behav Neurosci. 2014 May 30;8:195. doi: 10.3389/fnbeh.2014.00195. eCollection 2014.

44.

Metal-induced self-assembly of peroxiredoxin as a tool for sorting ultrasmall gold nanoparticles into one-dimensional clusters.

Ardini M, Giansanti F, Di Leandro L, Pitari G, Cimini A, Ottaviano L, Donarelli M, Santucci S, Angelucci F, Ippoliti R.

Nanoscale. 2014 Jul 21;6(14):8052-61. doi: 10.1039/c4nr01526f.

PMID:
24910403
45.

Thioredoxin reductase and its inhibitors.

Saccoccia F, Angelucci F, Boumis G, Carotti D, Desiato G, Miele AE, Bellelli A.

Curr Protein Pept Sci. 2014;15(6):621-46. Review.

46.

Effects of lithium and valproic acid on BDNF protein and gene expression in an in vitro human neuron-like model of degeneration.

Croce N, Mathé AA, Gelfo F, Caltagirone C, Bernardini S, Angelucci F.

J Psychopharmacol. 2014 Oct;28(10):964-72. doi: 10.1177/0269881114529379. Epub 2014 Apr 2.

PMID:
24699060
47.

Bihemispheric tDCS enhances language recovery but does not alter BDNF levels in chronic aphasic patients.

Marangolo P, Fiori V, Gelfo F, Shofany J, Razzano C, Caltagirone C, Angelucci F.

Restor Neurol Neurosci. 2014;32(2):367-79. doi: 10.3233/RNN-130323.

PMID:
24398720
48.

BDNF serum levels in subjects developing or not post-traumatic stress disorder after trauma exposure.

Angelucci F, Ricci V, Gelfo F, Martinotti G, Brunetti M, Sepede G, Signorelli M, Aguglia E, Pettorruso M, Vellante F, Di Giannantonio M, Caltagirone C.

Brain Cogn. 2014 Feb;84(1):118-22. doi: 10.1016/j.bandc.2013.11.012. Epub 2013 Dec 21.

PMID:
24362070
49.

Physiological effect of olfactory stimuli inhalation in humans: an overview.

Angelucci FL, Silva VV, Dal Pizzol C, Spir LG, Praes CE, Maibach H.

Int J Cosmet Sci. 2014 Apr;36(2):117-23. doi: 10.1111/ics.12096. Epub 2014 Jan 7. Review.

PMID:
24117755
50.

Switching between the alternative structures and functions of a 2-Cys peroxiredoxin, by site-directed mutagenesis.

Angelucci F, Saccoccia F, Ardini M, Boumis G, Brunori M, Di Leandro L, Ippoliti R, Miele AE, Natoli G, Scotti S, Bellelli A.

J Mol Biol. 2013 Nov 15;425(22):4556-68. doi: 10.1016/j.jmb.2013.09.002. Epub 2013 Sep 8.

PMID:
24021815

Supplemental Content

Loading ...
Support Center